Arbutus Biopharma Corpora...

NASDAQ: ABUS · Real-Time Price · USD
3.33
-0.04 (-1.19%)
At close: Aug 15, 2025, 3:59 PM
3.37
1.01%
After-hours: Aug 15, 2025, 05:47 PM EDT

Arbutus Biopharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-69.92M -72.85M -69.46M -76.25M
Depreciation & Amortization
1.38M 1.4M 1.43M 1.75M
Stock-Based Compensation
8.99M 9.3M 7.18M 6.42M
Other Working Capital
511K -18.23M 24.48M 517K
Other Non-Cash Items
-2.47M -5.56M -3.75M 7.79M
Deferred Income Tax
n/a n/a n/a -8.18M
Change in Working Capital
-2.83M -18.23M 29.24M 930K
Operating Cash Flow
-64.85M -85.94M -35.36M -67.53M
Capital Expenditures
-182K -1.01M -512K -809K
Cash Acquisitions
n/a n/a 458K 1.81M
Purchase of Investments
-141.51M -80.51M -130.43M -82.22M
Sales Maturities Of Investments
n/a 132.27M 56M 70.35M
Other Investing Acitivies
164.64M 20K -458K -1.81M
Investing Cash Flow
22.95M 50.77M -74.94M -12.68M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a -12.14M
Other Financial Acitivies
7.87M 795K 11.49M 14.71M
Financial Cash Flow
52M 30.65M 31.81M 137.24M
Net Cash Flow
10.04M -4.49M -78.51M 57.03M
Free Cash Flow
-65.03M -86.94M -35.87M -68.34M